Cite

HARVARD Citation

    Bardo-Brouard, P. et al. (2016). Stability of ipilimumab in its original vial after opening allows its use for at least 4 weeks and facilitates pooling of residues. European journal of cancer. pp. 8-16. [Online]. 
  
Back to record